Medical devices, healthcare technology and the business of care
PMA approval · P180032

Cerene Cryotherapy Device

Channel Medsystems, Inc. · Decision date Mar 28, 2019

FDA DECISIONP180032

What did the FDA approve?

FDA records P180032 as an original PMA application. The recorded decision is approval, dated Mar 28, 2019.

FDA approval order statement

Approval for the Cerene Cryotherapy Device. This device is indicated for endometrial cryoablation in premenopausal women with heavy menstrual bleeding due to benign causes for whom child bearing is complete.
Regulatory pathway
Original PMA
Clinical specialty
Obstetrics/Gynecology
Decision date
Mar 28, 2019

FDA source record

Regulatory record facts

Identifier
P180032
Regulatory pathway
Premarket approval application
Product code
MNB
Decision code
APPR
Decision date
Mar 28, 2019
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Product code
MNB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P180032 received

    Application receipt date recorded by FDA.

  2. P180032 · FDA decision

    APPR

  3. P180032/S024 · Related supplement

    Cerene Cryotherapy Device

  4. P180032/S025 · Related supplement

    Cerene Cryotherapy Device (Model number FGS-7000); Exhaust Collection Bag (Model number FGS-8000); Exhaust Collection Ba

Timeline entries are records held by MedtechLedger for P180032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180032

Product / regulatory recordCompanyPathwayDecision dateSource
Channel Medsystems, Inc.PMA supplementSep 15, 2026FDA
Channel Medsystems, Inc.PMA supplementNov 3, 2026FDA

Explore the linked device profile

Other records with product code MNB

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA supplementNov 5, 2026FDA
Axora Medical, Inc.PMA approvalJul 27, 2015FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Channel Medsystems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5858 Horton St., Suite 200, Emeryville, CA, 94608

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records